GlassScriptPhysician profile
Andrew J Chan
NPI 1356304273
$7,711.32
in general payments reported to CMS, 2019-2025
51 companies · $1,138 in 2025
The $1,138 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $948 · 2020: $448 · 2021: $742 · 2022: $1,543 · 2023: $1,804 · 2024: $1,087 · 2025: $1,138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,994 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,993.89 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,035.29 | 2019-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $790.19 | 2023-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $516.44 | 2019-2025 | Botox |
| Dendreon Pharmaceuticals LLC | $465.65 | 2019-2023 | Provenge |
| Astellas Pharma US INC | $450.12 | 2019-2025 | Xtandi, Myrbetriq |
| Endo Pharmaceuticals INC. | $387.41 | 2019-2024 | Xiaflex, Aveed |
| Bayer Healthcare Pharmaceuticals INC. | $374.54 | 2019-2025 | |
| Teleflex LLC | $367.44 | 2021-2025 | Urolift |
| Neotract INC. | $316.59 | 2019-2020 | |
| Coloplast Corp | $241.32 | 2019-2023 | Speedicath |
| Myovant Sciences INC. | $231.74 | 2021-2022 | |
| Pfizer INC. | $202.20 | 2019-2025 | |
| Urovant Sciences INC | $183.22 | 2022 | |
| Antares Pharma, INC. | $166.22 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Ferring Pharmaceuticals INC. | $161.15 | 2019-2025 | Adstiladrin |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.